Search research articles
Contact Us
Filters
Showing results (1151-1160 of 1,289) with videos related to
Page
of 129
Sort By:
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Blood
|
July 9, 1999
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease
P G Murray, L J Billingham, H T Hassan, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
October 5, 2010
Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma
Yolanda Piña, Hinda Boutrid, Timothy G Murray, et al.
Ophthalmology
|
November 18, 2020
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, et al.
The Journal of Hospital Infection
|
April 7, 2022
Change from transrectal to transperineal ultrasound-guided prostate biopsy under local anaesthetic eliminates sepsis as a complication
J W Power, J W Ryan, B Hutchinson, et al.
Journal of Vitreoretinal Diseases
|
October 4, 2021
Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis
Andre J Witkin, Paul Hahn, Timothy G Murray, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist
J R Tagat, R W Steensma, S W McCombie, et al.
American Journal of Human Genetics
|
June 2, 2009
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1
Dan Hanson, Philip G Murray, Amit Sud, et al.
Transplantation
|
January 2, 2004
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
Edmund Q Sanchez, Marlon F Levy, Robert M Goldstein, et al.
Blood
|
December 7, 2006
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
Amanda Dutton, Ciaran B Woodman, Marilyn B Chukwuma, et al.
Page
of 129
Search research articles
Search
Showing results (1151-1160 of 1,289) with videos related to
Sort By:
Page
of 129
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Blood
|
July 9, 1999
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease
P G Murray, L J Billingham, H T Hassan, et al.
Journal of Pediatric Ophthalmology and Strabismus
|
October 5, 2010
Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma
Yolanda Piña, Hinda Boutrid, Timothy G Murray, et al.
Ophthalmology
|
November 18, 2020
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, et al.
The Journal of Hospital Infection
|
April 7, 2022
Change from transrectal to transperineal ultrasound-guided prostate biopsy under local anaesthetic eliminates sepsis as a complication
J W Power, J W Ryan, B Hutchinson, et al.
Journal of Vitreoretinal Diseases
|
October 4, 2021
Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis
Andre J Witkin, Paul Hahn, Timothy G Murray, et al.
Journal of Medicinal Chemistry
|
October 5, 2001
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist
J R Tagat, R W Steensma, S W McCombie, et al.
American Journal of Human Genetics
|
June 2, 2009
The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1
Dan Hanson, Philip G Murray, Amit Sud, et al.
Transplantation
|
January 2, 2004
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation
Edmund Q Sanchez, Marlon F Levy, Robert M Goldstein, et al.
Blood
|
December 7, 2006
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
Amanda Dutton, Ciaran B Woodman, Marilyn B Chukwuma, et al.
Page
of 129